Common Contracts
2 similar Collaboration Agreement contracts by OKYO Pharma LTD
AMENDMENT No. 1 TO COLLABORATION AGREEMENT BETWEEN TUFTS MEDICAL CENTER, INC AND OKYO PHARMA LIMITEDCollaboration Agreement • March 4th, 2022 • OKYO Pharma LTD • Biological products, (no disgnostic substances)
THIS AMENDMENT is entered into as of the date of last signature below by and between Tufts Medical Center, Inc., a not-for-profit tax-exempt corporation organized under the laws of the Commonwealth of Massachusetts with its principal place of business at 800 Washington Street, Boston, MA 02111 (“Tufts MC”), and Okyo Pharma Limited, a limited liability company incorporated and registered in Guernsey whose registered office and principal place of business is at Martello Court, Admiral Park, St. Peter Port, Guernsey GYI 3HB (“OKYO”).
AMENDMENT No. 1 TO COLLABORATION AGREEMENT BETWEEN TUFTS MEDICAL CENTER, INC AND OKYO PHARMA LIMITEDCollaboration Agreement • May 21st, 2021 • OKYO Pharma LTD • Biological products, (no disgnostic substances)
THIS AMENDMENT is entered into as of the date of last signature below by and between Tufts Medical Center, Inc., a not-for-profit tax-exempt corporation organized under the laws of the Commonwealth of Massachusetts with its principal place of business at 800 Washington Street, Boston, MA 02111 (“Tufts MC”), and Okyo Pharma Limited, a limited liability company incorporated and registered in Guernsey whose registered office and principal place of business is at Martello Court, Admiral Park, St. Peter Port, Guernsey GYI 3HB (“OKYO”).
